Exclusive: Clinical-Stage Specialty Pharma EyeGate CEO On Relationship With Valeant

By: via Benzinga
Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) entered into a licensing agreement with Valeant Pharmaceuticals Intl Inc (NYSE: VRX) Tuesday ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.